Some of the most difficult-to-treat patients with pulmonary hypertension are those with chronic thromboembolic pulmonary hypertension (CTEPH).
Articles by Maureen Newman
Endothelin-receptor antagonists (ERAs), recently discussed on Pulmonary Hypertension News as…
Pulmonary hypertension (PH) on its own is…
Early detection of chronic thromboembolic pulmonary hypertension (CTEPH) is vital to addressing and potentially preventing the most…
More often than not, risk factors for and development rates of cardiovascular diseases vary according to race…
Pulmonary hypertension can be a devastating disease, especially when it impacts infants and children. A new study in…
As new medications for pulmonary hypertension are approved and marketed, it is important to evaluate their efficacy, both absolutely…
Inhalation of a small molecule known as PK10453, formally known as (R-phenyl)pyrazin-R-methylnicotinamide, prevented pulmonary arterial hypertension progression in rats…
As any scleroderma patient knows, the disease has no cure and no effective treatments exist. The main goal of…
Scleroderma patients, who are sometimes affected by pulmonary…
Any newly-diagnosed pulmonary arterial hypertension (PAH) patient could probably testify to the hardships of having the disease, and new…
Putting an end to one familial case of pulmonary arterial hypertension (PAH) without a known cause, a recent study…